Why the study?
Does ambroxol improve postoperative pulmonary function in patients undergoing on-pump coronary artery bypass grafting?
Does ambroxol improve postoperative pulmonary function in patients undergoing on-pump coronary artery bypass grafting?
Ambroxol improves postoperative pulmonary function tests and oxygenation after on-pump CABG, but without significant clinical benefit.
Answers are grounded in this paper and cite their sources.
Ambroxol should not be used routinely post-CABG; challenges reliance on surrogate pulmonary endpoints in future trials.
In on-pump coronary artery bypass grafting, ambroxol improves postoperative PFTs and PaO2 levels without any significant clinical implication, and it exerts these effects possibly in ways other than surfactant modulation.
No takes yet. Share an insight, caveat, or question.
Ulaş et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: